Maria Łastowska

3.4k total citations
40 papers, 1.6k citations indexed

About

Maria Łastowska is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, Maria Łastowska has authored 40 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 21 papers in Molecular Biology and 13 papers in Genetics. Recurrent topics in Maria Łastowska's work include Neuroblastoma Research and Treatments (24 papers), Glioma Diagnosis and Treatment (11 papers) and Neuroendocrine Tumor Research Advances (9 papers). Maria Łastowska is often cited by papers focused on Neuroblastoma Research and Treatments (24 papers), Glioma Diagnosis and Treatment (11 papers) and Neuroendocrine Tumor Research Advances (9 papers). Maria Łastowska collaborates with scholars based in United Kingdom, Poland and United States. Maria Łastowska's co-authors include Nick Bown, Andrew D.J. Pearson, Simon Cotterill, C. Brinkschmidt, Dominique Plantaz, Geneviève Laureys, Holger Christiansen, Paul Roberts, Michael S. Jackson and A G McGuckin and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Nature Cell Biology.

In The Last Decade

Maria Łastowska

39 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Łastowska United Kingdom 20 1.2k 925 483 340 257 40 1.6k
Cynthia Winter United States 12 928 0.8× 808 0.9× 536 1.1× 328 1.0× 176 0.7× 15 1.3k
Naomi L. Bowers United Kingdom 21 729 0.6× 557 0.6× 172 0.4× 215 0.6× 208 0.8× 38 1.4k
Delphine Lequin France 6 717 0.6× 618 0.7× 370 0.8× 299 0.9× 84 0.3× 10 1.0k
I.M. Ambros Austria 14 852 0.7× 472 0.5× 334 0.7× 170 0.5× 117 0.5× 17 1.2k
M.Elena Kusak Spain 20 448 0.4× 621 0.7× 352 0.7× 154 0.5× 134 0.5× 42 1.3k
Dolores Arjona Spain 21 276 0.2× 727 0.8× 259 0.5× 158 0.5× 190 0.7× 38 1.2k
Kathy Astrahantseff Germany 17 449 0.4× 645 0.7× 383 0.8× 308 0.9× 84 0.3× 36 1.2k
T. Shane Shih United States 8 692 0.6× 690 0.7× 112 0.2× 222 0.7× 116 0.5× 9 1.4k
Fred Gilbert United States 7 593 0.5× 670 0.7× 295 0.6× 206 0.6× 284 1.1× 8 1.1k
M. Josefa Bello Spain 30 844 0.7× 1.2k 1.3× 584 1.2× 343 1.0× 249 1.0× 78 2.5k

Countries citing papers authored by Maria Łastowska

Since Specialization
Citations

This map shows the geographic impact of Maria Łastowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Łastowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Łastowska more than expected).

Fields of papers citing papers by Maria Łastowska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Łastowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Łastowska. The network helps show where Maria Łastowska may publish in the future.

Co-authorship network of co-authors of Maria Łastowska

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Łastowska. A scholar is included among the top collaborators of Maria Łastowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Łastowska. Maria Łastowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Xiaohua, Xiaoping Wu, Kalen Berry, et al.. (2023). Nuclear condensates of YAP fusion proteins alter transcription to drive ependymoma tumourigenesis. Nature Cell Biology. 25(2). 323–336. 36 indexed citations
2.
Trubicka, Joanna, Maria Łastowska, Agnieszka Karkucińska‐Więckowska, et al.. (2023). BCOR expression in paediatric pineoblastoma. Folia Neuropathologica. 61(2). 121–128.
3.
Wakulińska, Anna, Agnieszka Karkucińska‐Więckowska, Bożenna Dembowska–Bagińska, et al.. (2019). OLIG2 is a novel immunohistochemical marker associated with the presence of PAX3/7-FOXO1 translocation in rhabdomyosarcomas. Diagnostic Pathology. 14(1). 103–103. 10 indexed citations
4.
Łastowska, Maria, Joanna Trubicka, Agnieszka Karkucińska‐Więckowska, et al.. (2018). Immunohistochemical detection of ALK protein identifies APC mutated medulloblastoma and differentiates the WNT-activated medulloblastoma from other types of posterior fossa childhood tumors. Brain Tumor Pathology. 36(1). 1–6. 6 indexed citations
5.
Trubicka, Joanna, Piotr Iwanowski, Małgorzata Rydzanicz, et al.. (2017). Constitutional mosaicism of a de novo TP53 mutation in a patient with bilateral choroid plexus carcinoma. Cancer Genetics. 216-217. 79–85. 9 indexed citations
6.
Trubicka, Joanna, Tomasz Żemojtel, Jochen Hecht, et al.. (2017). The germline variants in DNA repair genes in pediatric medulloblastoma: a challenge for current therapeutic strategies. BMC Cancer. 17(1). 239–239. 12 indexed citations
7.
Trubicka, Joanna, Małgorzata Szperl, Wiesława Grajkowska, et al.. (2016). Identification of a novel inherited ALK variant M1199L in the WNT type of medulloblastoma. Folia Neuropathologica. 1(1). 23–30. 9 indexed citations
8.
Łastowska, Maria, Elżbieta Jurkiewicz, Joanna Trubicka, et al.. (2015). Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours. Journal of Neuro-Oncology. 123(1). 65–73. 26 indexed citations
9.
Skalniak, Anna, Sylwia D. Tyrkalska, Irena Horwacik, et al.. (2014). Expression of the monocyte chemotactic protein-1-induced protein 1 decreases human neuroblastoma cell survival. Oncology Reports. 31(5). 2385–2392. 26 indexed citations
10.
Łastowska, Maria, Hani Al-Afghani, Haya H. Al‐Balool, et al.. (2013). Identification of a neuronal transcription factor network involved inmedulloblastoma development. Acta Neuropathologica Communications. 1(1). 35–35. 34 indexed citations
11.
Moore, Hannah C., Katrina Wood, Michael S. Jackson, et al.. (2008). Histological profile of tumours from MYCN transgenic mice. Journal of Clinical Pathology. 61(10). 1098–1103. 33 indexed citations
12.
Łastowska, Maria, Virginie Viprey, Mauro Santibanez‐Koref, et al.. (2007). Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data. Oncogene. 26(53). 7432–7444. 76 indexed citations
13.
Vandesompele, Jo, Michael Baudis, Katleen De Preter, et al.. (2005). Unequivocal Delineation of Clinicogenetic Subgroups and Development of a New Model for Improved Outcome Prediction in Neuroblastoma. Journal of Clinical Oncology. 23(10). 2280–2299. 132 indexed citations
14.
Vandesompele, Jo, Frank Speleman, Nadine Van Roy, et al.. (2001). Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?. Medical and Pediatric Oncology. 36(1). 5–10. 70 indexed citations
15.
Bown, Nick, Simon Cotterill, Maria Łastowska, et al.. (1999). Gain of Chromosome Arm 17q and Adverse Outcome in Patients with Neuroblastoma. New England Journal of Medicine. 340(25). 1954–1961. 373 indexed citations
16.
Łastowska, Maria, E Nacheva, A G McGuckin, et al.. (1997). Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group.. PubMed. 18(3). 162–9. 85 indexed citations
17.
Łastowska, Maria, Debra M. Lillington, Andrew N. Shelling, et al.. (1994). Fluorescence in situ hybridization analysis using cosmid probes to define chromosome 6q abnormalities in ovarian carcinoma cell lines. Cancer Genetics and Cytogenetics. 77(2). 99–105. 17 indexed citations
18.
Attard-Montalto, Simon, et al.. (1994). Non-Hodgkin's Lymphoma and Klinefelter Syndrome. Pediatric Hematology and Oncology. 11(2). 197–200. 16 indexed citations
19.
Balwierz, Walentyna, et al.. (1989). Acute lymphoblastic leukaemia therapy in Poland. A report from the Polish Children's Leukaemia/Lymphoma Study Group.. PubMed. 116(2). 199–210. 5 indexed citations
20.
Łastowska, Maria, et al.. (1988). [Preliminary evaluation of the results of treatment of myeloblastic leukemia using the AML-BFM-83 protocol based on data from the Polish Group for the Treatment of Leukemia in Children].. PubMed. 43(11). 376–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026